These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35777453)

  • 1. A gene expression biomarker identifies inhibitors of two classes of epigenome effectors in a human microarray compendium.
    Corton JC; Liu J; Williams A; Cho E; Yauk CL
    Chem Biol Interact; 2022 Sep; 365():110032. PubMed ID: 35777453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of the TGx-HDACi transcriptomic biomarker to detect histone deacetylase inhibitors in human TK6 cells.
    Cho E; Rowan-Carroll A; Williams A; Corton JC; Li HH; Fornace AJ; Hobbs CA; Yauk CL
    Arch Toxicol; 2021 May; 95(5):1631-1645. PubMed ID: 33770205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transcriptomic dataset used to derive biomarkers of chemically induced histone deacetylase inhibition (HDACi) in human TK6 cells.
    Cho E; Williams A; Yauk CL
    Data Brief; 2021 Jun; 36():107097. PubMed ID: 34036128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone Deacetylase Inhibitors (HDACi) Cause the Selective Depletion of Bromodomain Containing Proteins (BCPs).
    Mackmull MT; Iskar M; Parca L; Singer S; Bork P; Ori A; Beck M
    Mol Cell Proteomics; 2015 May; 14(5):1350-60. PubMed ID: 25755299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of p53 Activators in a Human Microarray Compendium.
    Corton JC; Witt KL; Yauk CL
    Chem Res Toxicol; 2019 Sep; 32(9):1748-1759. PubMed ID: 31397557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the performance of the TGx-DDI biomarker to detect DNA damage-inducing agents using quantitative RT-PCR in TK6 cells.
    Cho E; Buick JK; Williams A; Chen R; Li HH; Corton JC; Fornace AJ; Aubrecht J; Yauk CL
    Environ Mol Mutagen; 2019 Mar; 60(2):122-133. PubMed ID: 30488505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines.
    LaBonte MJ; Wilson PM; Fazzone W; Groshen S; Lenz HJ; Ladner RD
    BMC Med Genomics; 2009 Nov; 2():67. PubMed ID: 19948057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 50-gene biomarker identifies estrogen receptor-modulating chemicals in a microarray compendium.
    Corton JC; Matteo G; Chorley B; Liu J; Vallanat B; Everett L; Atlas E; Meier MJ; Williams A; Yauk CL
    Chem Biol Interact; 2024 May; 394():110952. PubMed ID: 38570061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the TGx-28.65 transcriptomic biomarker to classify genotoxic and non-genotoxic chemicals in human TK6 cells in the presence of rat liver S9.
    Yauk CL; Buick JK; Williams A; Swartz CD; Recio L; Li HH; Fornace AJ; Thomson EM; Aubrecht J
    Environ Mol Mutagen; 2016 May; 57(4):243-60. PubMed ID: 26946220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Gene Expression Biomarker Predicts Heat Shock Factor 1 Activation in a Gene Expression Compendium.
    Cervantes PW; Corton JC
    Chem Res Toxicol; 2021 Jul; 34(7):1721-1737. PubMed ID: 34170685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the Cancer Epigenome with Histone Deacetylase Inhibitors in Osteosarcoma.
    Collier CD; Getty PJ; Greenfield EM
    Adv Exp Med Biol; 2020; 1258():55-75. PubMed ID: 32767234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moving Toward Integrating Gene Expression Profiling Into High-Throughput Testing: A Gene Expression Biomarker Accurately Predicts Estrogen Receptor α Modulation in a Microarray Compendium.
    Ryan N; Chorley B; Tice RR; Judson R; Corton JC
    Toxicol Sci; 2016 May; 151(1):88-103. PubMed ID: 26865669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using a gene expression biomarker to identify DNA damage-inducing agents in microarray profiles.
    Corton JC; Williams A; Yauk CL
    Environ Mol Mutagen; 2018 Dec; 59(9):772-784. PubMed ID: 30329178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells.
    Dejligbjerg M; Grauslund M; Litman T; Collins L; Qian X; Jeffers M; Lichenstein H; Jensen PB; Sehested M
    Mol Cancer; 2008 Sep; 7():70. PubMed ID: 18789133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses.
    Bolden JE; Shi W; Jankowski K; Kan CY; Cluse L; Martin BP; MacKenzie KL; Smyth GK; Johnstone RW
    Cell Death Dis; 2013 Feb; 4(2):e519. PubMed ID: 23449455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNH1 regulation of reactive oxygen species contributes to histone deacetylase inhibitor resistance in gastric cancer cells.
    Zhu Y; Das K; Wu J; Lee MH; Tan P
    Oncogene; 2014 Mar; 33(12):1527-37. PubMed ID: 23584480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAC inhibition results in widespread alteration of the histone acetylation landscape and BRD4 targeting to gene bodies.
    Slaughter MJ; Shanle EK; Khan A; Chua KF; Hong T; Boxer LD; Allis CD; Josefowicz SZ; Garcia BA; Rothbart SB; Strahl BD; Davis IJ
    Cell Rep; 2021 Jan; 34(3):108638. PubMed ID: 33472068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase (HDAC) inhibitor kinetic rate constants correlate with cellular histone acetylation but not transcription and cell viability.
    Lauffer BE; Mintzer R; Fong R; Mukund S; Tam C; Zilberleyb I; Flicke B; Ritscher A; Fedorowicz G; Vallero R; Ortwine DF; Gunzner J; Modrusan Z; Neumann L; Koth CM; Lupardus PJ; Kaminker JS; Heise CE; Steiner P
    J Biol Chem; 2013 Sep; 288(37):26926-43. PubMed ID: 23897821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase class-I inhibition promotes epithelial gene expression in pancreatic cancer cells in a BRD4- and MYC-dependent manner.
    Mishra VK; Wegwitz F; Kosinsky RL; Sen M; Baumgartner R; Wulff T; Siveke JT; Schildhaus HU; Najafova Z; Kari V; Kohlhof H; Hessmann E; Johnsen SA
    Nucleic Acids Res; 2017 Jun; 45(11):6334-6349. PubMed ID: 28369619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors.
    Kortenhorst MS; Wissing MD; Rodríguez R; Kachhap SK; Jans JJ; Van der Groep P; Verheul HM; Gupta A; Aiyetan PO; van der Wall E; Carducci MA; Van Diest PJ; Marchionni L
    Epigenetics; 2013 Sep; 8(9):907-20. PubMed ID: 23880963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.